Buttorff Leslie's Form 4 filing
Panacea Life Sciences Holdings, Inc. (PLSH) · filed May 9, 2023
- Accession no.
- 0001493152-23-016009
- Filed
- May 9, 2023, 7:11 PM ET
- Trade date
- May 5-9, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $7.15K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Buttorff LeslieCIK 0001866792 | Director, Officer (CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 5, 2023 | Common Stock | PPurchaseAcquired | +11,500 | $0.49 | +$5,635 | 738,149 | Direct | |
| May 8, 2023 | Common Stock | PPurchaseAcquired | +1,500 | $0.43 | +$645 | 739,649 | Direct | |
| May 9, 2023 | Common Stock | PPurchaseAcquired | +2,300 | $0.377 | +$867.1 | 741,949 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.